Oregon Statutes 689.813 – Exemption from drug labeling requirements
(1) A requirement that a health care provider who is authorized to prescribe drugs in this state label a drug dispensed by the health care provider with the information described in subsection (2) of this section does not apply to a drug approved by the United States Food and Drug Administration for the reversal of an opioid overdose if the drug is:
Terms Used In Oregon Statutes 689.813
- dispensing: means the preparation and delivery of a prescription drug pursuant to a lawful order of a practitioner in a suitable container appropriately labeled for subsequent administration to or use by a patient or other individual entitled to receive the prescription drug. See Oregon Statutes 689.005
- Manufacturer: means a person engaged in the manufacture of drugs. See Oregon Statutes 689.005
- Pharmacy: means a place that meets the requirements of rules of the board, is licensed and approved by the board where the practice of pharmacy may lawfully occur and includes apothecaries, drug stores, dispensaries, hospital outpatient pharmacies, pharmacy departments and prescription laboratories but does not include a place used by a manufacturer or wholesaler. See Oregon Statutes 689.005
- United States: includes territories, outlying possessions and the District of Columbia. See Oregon Statutes 174.100
(a) In the form of a nasal spray; and
(b) Personally dispensed by a health care provider described in this subsection at the location of practice of the health care provider.
(2) The information described in subsection (1) of this section includes:
(a) The name of the patient;
(b) The name and address of the dispensing health care provider;
(c) The date of dispensing;
(d)(A) The name of the drug or, if the dispensed drug does not have a brand name, the generic name of the drug along with the name of the drug distributor or manufacturer;
(B) The drug’s quantity per unit, unless the drug is a compound; and
(C) The directions for the drug’s use stated in the prescription;
(e) Cautionary statements, if any, as required by law; and
(f) When applicable and as determined by the State Board of Pharmacy, an expiration date after which the patient should not use the drug. [2023 c.285 § 2]
[Formerly 689.740; 1975 c.484 § 1; repealed by 1979 c.777 § 59]
[1973 c.533 § 2; 1975 c.369 § 2; 1979 c.785 § 11; repealed by 1979 c.777 § 59]
[1975 c.218 § 2; repealed by 1979 c.777 § 59]
PENALTIES